This paper analyses the impact of sugar availability/intake on diabetes expenditure and on total health care expenditure. Building this macroeconomic analysis upon the literature on the determinants of health care expenditure, we estimate a dynamic panel data model over a sample of 156 countries for the period 1995–2014. After controlling for the traditional determinants of health care spending, we find that an increase in sugar availability/intake leads to a significant rise in diabetes expenditure (per capita and per diabetic) and in the growth rate of total health care expenditure per capita. Moreover, we show that this causal relation is present in both developed and developing countries.
Funding
This research was financially supported by the Portuguese Foundation for Science and Technology under the research grant SFRH/BSAB/113588/2015 (partially funded by COMPTE, QREN and FEDER).
History
School
Business and Economics
Department
Economics
Published in
Health Economics
Citation
CASTRO, V., 2017. Pure, white and deadly… expensive: a bitter sweetness in health care expenditure. Health Economics, 26 (12), pp.1644–1666.
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/
Acceptance date
2016-11-09
Publication date
2017
Notes
This is the peer reviewed version of the following article: CASTRO, V., 2017. Pure, white and deadly… expensive: a bitter sweetness in health care expenditure. Health Economics, 26 (12), pp.1644–1666, which has been published in final form at http://dx.doi.org/10.1002/hec.3462. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.